1. Being a technician during COVID-19: a qualitative cross-sectional survey on the experiences of clinical neurophysiology technicians

   • Francesca Sireci
   • Elena Bellei
   • Franco Valzania

   COVID-19 13 December 2022 Pages: 429 - 436

2. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)

   • Filippo Martinelli-Boneschi
   • Antonio Colombo
   • Andrea Salmaggi

   COVID-19 Open access 26 October 2022 Pages: 437 - 446

   

3. COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation

   • Assunta Trinchillo
   • Marcello Esposito
   • Bernardo Maria De Martino

   Covid-19 25 December 2022 Pages: 447 - 450

4. First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2

   • Shu Umezawa
   • Katsura Ioka
   • Kazuo Yoshizawa

   COVID-19 27 October 2022 Pages: 451 - 455

   

5. Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination

   • Aggeliki Fotiadou
   • Dimitrios Tsiptsios
   • Ioannis Iliopoulos

   COVID-19 03 November 2022 Pages: 457 - 459

   

6. Physical therapy interventions for the management of hand tremors in patients with Parkinson’s disease: a systematic review

   • Mostafa Shahien
   • Abdelrahman Elaraby
   • Ahmed Negida

   Review Article 07 October 2022 Pages: 461 - 470

   

7. The impact of leptomeningeal collaterals in acute ischemic stroke: a systematic review and meta-analysis

   • Ahmed Mohamed
   • Ashfaq Shuaib
   • Nida Fatima

   Review Article 04 October 2022 Pages: 471 - 489

   

8. Intravenous thrombolysis in CADASIL: report of two cases and a systematic review

   • Francesca Pescini
   • Sara Torricelli
   • Leonardo Pantoni

   Review Article Open access 18 October 2022 Pages: 491 - 498

   

9. Diagnostic performance of artificial intelligence in multiple sclerosis: a systematic review and meta-analysis

   • Fardin Nabizadeh
   • Elham Ramezannezhad
   • Ali Ghaderi

   Review Article 27 October 2022 Pages: 499 - 517

   

10. The efficacy of laser interstitial thermal therapy in the management of spinal metastases: a systematic review of the literature

    • Andrea Cardia
    • Delia Cannizzaro
    • Ismail Zaed

    Review Article 01 October 2022 Pages: 519 - 528

    

11. Teleneuropsychology: normative data for the assessment of memory in online settings

    • Ezia Rizzi
    • Michela Vezzoli
    • Roberta Daini

    Original Article Open access 05 October 2022 Pages: 529 - 538

    

12. Sexual needs and sexual function of patients with Parkinson’s disease

    • G. Bronner
    • S. Peleg-Nesher
    • T. Gurevich

    Original Article 26 October 2022 Pages: 539 - 546

13. Predictors of anxiety in Parkinson’s disease: results from a 3-year longitudinal cohort study

    • Jessie S. Gibson
    • Joseph L. Flanigan
    • Madaline B. Harrison

    Original Article Open access 11 October 2022 Pages: 547 - 556

14. The mediating effects of depression, anxiety, and rapid eye movement sleep behavior disorder on the association between dopaminergic replacement therapy and impulse control disorders in Parkinson’s disease

    • Sidan Du
    • Ying Huang
    • Hongmei Yu

    Original Article 12 October 2022 Pages: 557 - 564

    

15. Screening for impulse control disorders in Parkinson’s disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors

    • Manuela Contin
    • Giovanna Lopane
    • Giovanna Calandra-Buonaura

    Original Article 09 November 2022 Pages: 565 - 572

    

16. Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson’s disease

    • Fardin Nabizadeh
    • Kasra Pirahesh
    • Elham Ramezannezhad

    Original Article 13 October 2022 Pages: 573 - 585

    

17. Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis

    • Edoardo Nicolò Aiello
    • Federica Solca
    • Barbara Poletti

    Original Article Open access 06 October 2022 Pages: 587 - 592

    

18. Prevalence of motor neuron diseases in gout patients: a nationwide population-based cohort study

    • Hyuk Sung Kwon
    • Yeonjae Park
    • Hojin Choi

    Original Article 22 October 2022 Pages: 593 - 600

    

19. Cognitive impairment in asymptomatic cerebral arterial stenosis: a P300 study

    • Nevine El Nahas
    • Amr Zaki
    • Ahmed El Bokl

    Original Article Open access 19 October 2022 Pages: 601 - 609

    

20. Multiple chronic lacunes predicting early neurological deterioration and long-term functional outcomes according to TOAST classification in acute ischemic stroke

    • Hyuk-je Lee
    • Taewon Kim
    • Sung-Woo Chung

    Original Article 18 October 2022 Pages: 611 - 619

    

21. Clinical and imaging predictors of dysphagia and swallowing ability recovery in acute ischemic stroke

    • Xiao Hu
    • Mingjun Pu
    • Qi Li

    Original Article 27 October 2022 Pages: 621 - 629

    

22. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy-related inflammation (CAA-ri): retrospective, observational experience of a single centre

    • Dan Li
    • Weiwei Qin
    • Weizhou Zang

    Original Article 07 October 2022 Pages: 631 - 638

    

23. Clinical features and pathogenicity assessment in patients with HTRA1-autosomal dominant disease

    • Zheng He
    • Lijun Wang
    • Yanliang Niu

    Original Article 18 October 2022 Pages: 639 - 647

    

24. Network localization of transient global amnesia beyond the hippocampus

    • Tao Wang
    • Yicheng Xu
    • Shengyuan Yu

    Original Article 12 October 2022 Pages: 649 - 657

    

25. Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?

    • Sepideh Paybast
    • Mohammad Amin Habibi
    • Abdorreza Naser Moghadasi

    Original Article 18 October 2022 Pages: 659 - 665

26. Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis

    • Ricardo Alonso
    • María Bárbara Eizaguirre
    • Edgar Carnero Contentti

    Original Article 02 November 2022 Pages: 667 - 676

27. Blood pressure and cognition in older adults with multiple sclerosis: preliminary examination

    • Robert W. Motl
    • Jessica F. Baird
    • Bo Fernhall

    Original Article 26 October 2022 Pages: 677 - 683

28. Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study

    • Massimiliano Pau
    • Micaela Porta
    • Eleonora Cocco

    Original Article Open access 19 October 2022 Pages: 685 - 691

29. First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

    • Charalampos Skarlis
    • Nikolaos Markoglou
    • Maria Anagnostouli

    Original Article Open access 05 October 2022 Pages: 693 - 701

    

30. Is there a time window for MRI in Wernicke encephalopathy — a decade of experience from a tertiary hospital

    • Ana Rita Silva
    • Sofia Almeida-Xavier
    • Sara Varanda

    Original Article 05 November 2022 Pages: 703 - 708

    

31. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer’s disease compared to neurological disease controls: a retrospective study on 276 patients

    • Eleonora Giacopuzzi Grigoli
    • Federica Solca
    • Federico Verde

    Brief Communication 28 November 2022 Pages: 709 - 713

    

32. Anterior lumbosacral polyradiculoneuropathy following intrathecal methotrexate administration: a case report and literature update

    • Annamaria Landolfi
    • Claudia Vinciguerra
    • Giuseppe Piscosquito

    Brief Communication 23 November 2022 Pages: 715 - 718

    

33. Distal upper limb involvement in myasthenia-myositis association

    • Antonio Lauletta
    • Laura Fionda
    • Matteo Garibaldi

    Brief Communication 07 November 2022 Pages: 719 - 722

    

34. Feasibility of therapeutic music listening in fibromyalgia: a randomised controlled pilot study

    • Alfredo Raglio
    • Raffaella Bettaglio
    • Laura Demartini

    Brief Communication 05 November 2022 Pages: 723 - 727

    

35. Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment?

    • Claudia Frau
    • Carla Masala
    • Giovanni Defazio

    Letter to the Editor 11 October 2022 Pages: 729 - 730

36. Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study

    • Angelo Pascarella
    • Lucia Manzo
    • Anna Estraneo

    Letter to the Editor 12 October 2022 Pages: 731 - 734

    

37. Cognitive impairment in ALS has been known since the nineteenth century

    • Philippe Corcia
    • Philippe Couratier

    Letter to the Editor 30 September 2022 Pages: 735 - 736

38. Presence of anti-IgLON5 antibody in a case of sporadic Creutzfeldt–Jakob disease with sleep disturbance as a prominent symptom

    • Zhongyun Chen
    • Jing Zhang
    • Liyong Wu

    Letter to the Editor Open access 06 October 2022 Pages: 737 - 740

    

39. Anti-NMDA receptor encephalitis with “Hockey stick sign” mimicking CJD

    • Sarvesh Kumar Chaudhary
    • Ajay Chavan
    • Ruchika Tandon

    Letter to the Editor 17 October 2022 Pages: 741 - 743

    

40. Anti-amphiphysin associated paraneoplastic diencephalitis secondary to a thymic neuroendocrine tumour

    • Aaron Jesuthasan
    • Peter McColgan
    • Yen F. Tai

    Letter to the Editor 04 October 2022 Pages: 745 - 748

    

41. Selective dystextia secondary to a left frontal hemorrhagic infarct

    • Wen-Ching Chen
    • Poyin Huang

    Letter to the Editor 27 September 2022 Pages: 749 - 751

    

42. A healthy outcome of a pregnant woman with drug-resistant juvenile myoclonic epilepsy treated with brivaracetam

    • Cristian Eduardo Navarro

    Letter to the Editor 12 October 2022 Pages: 753 - 755

43. Efficacy and tolerability of perampanel in a patient with Late-Onset myoclonic epilepsy in Down syndrome (LOMEDS): a case report

    • Clarissa Corniello
    • Fedele Dono
    • Stefano L. Sensi

    Letter to the Editor 18 October 2022 Pages: 757 - 760

    

44. Delayed post-hypoxic leukoencephalopathy following opioid intoxication

    • Francesco Brovelli
    • Lorenzo Saraceno
    • Elio Clemente Agostoni

    Letter to the Editor 10 October 2022 Pages: 761 - 763

    

45. A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke

    • Hany M. Aref
    • Hala El-Khawas
    • Tamer M. Roushdy

    Clinical Trial article Open access 30 November 2022 Pages: 765 - 771

    

46. Basilar artery dolichoectasia presenting as transverse pontine infarction and “nine syndrome”

    • Shugang Cao
    • Rongfeng Wang
    • Mingwu Xia

    Neuro-Images 28 October 2022 Pages: 773 - 774

    

47. Salt-and-pepper appearance pontine and cerebellar enhancing lesions in CLIPPERS

    • Kundian Guo
    • Zhen Hong

    Neuro-Images 02 November 2022 Pages: 775 - 776

    

48. A patient carrying a heterozygous p.Asn267Ser TARDBP missense mutation diagnosed as ALS and only involving lower motor neurons

    • Shan Jin
    • Zhengzhe Sun
    • Wenming Yang

    Update in Clinical Neurogenetics 17 December 2022 Pages: 777 - 782

    

49. Correction to: Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

    • Monica Puligheddu
    • Michela Figorilli
    • the FARPRESTO Consortium

    Correction Open access 07 November 2022 Pages: 783 - 783

50. Correction to: Clinical presentation of strokes confined to the insula: a systematic review of literature

    • Vincenzo Di Stefano
    • Maria Vittoria De Angelis
    • Robert Simister

    Correction Open access 22 September 2022 Pages: 785 - 785